H4 Orphan Pharma works every day to develop innovative treatments for patients with unmet medical needs in fibrotic diseases, specifically in the fields of:

  • respiratory diseases
  • ophtalmological diseases

H4 Orphan Pharma was founded in 2016 by a physician (Gaëtan Terrasse) and two pharmacists (Catherine Bur and Vincent Cotereau).

Our team calls upon its extensive pharmaceutical expertise to deploy a new development model based on resource optimization. Through it, we create productive partnerships with leading international experts in clinical medicine, chemistry and pharmacology.